More than 40 states say the biggest drug makers engaged in “industry-wide conspiracy” to fix prices of generic drugs

Quick Read

In Indiana, a local hospital system, Parkview Health, charged private insurance companies about quadruple what the federal Medicare program paid for the same care, according to a study of hospital prices in 25 states released on Thursday by the nonprofit RAND Corp

Quick Read

Novartis AG is expected to begin selling Zolgensma, a possible cure for spinal muscular atrophy, after the FDA approves it this month. Novartis executives say Zolgensma’s ability to curb SMA—a muscle-wasting disease that often kills babies before age 2—explains the eye-popping price

Quick Read

Summer Bummer

April 30, 2019

The snake struck a 9-year-old hiker at dusk on a nature trail. The outrageous bills struck her parents a few weeks later

Quick Read

Bob Field was set to kick off his second course of BCG — a potent immunotherapy that treats his fast-growing bladder cancer. Instead, the New York City banking executive got a call from his urologist’s office, canceling that week’s appointment

Quick Read

Big pharma is partnering with influencers to sell new drugs and medical devices

Quick Read

Delta Dental of California is facing mounting criticism for paying its CEO exorbitantly, flying board members and their companions to Barbados for a meeting, and spending a small fraction of its revenue on charitable work — all while receiving significant state and federal tax breaks because of its nonprofit status

Quick Read

A new study links marketing for opioids to more overdose deaths

Quick Read